Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ: 072020)

Market Cap	95.59B
Revenue (ttm)	39.19B
Net Income (ttm)	3.65B
Shares Out	9.56M
EPS (ttm)	375.11
PE Ratio	26.66
Forward PE	n/a
Dividend	150.00 (1.49%)
Ex-Dividend Date	n/a

Volume	17,526
Open	10,090
Previous Close	10,100
Day's Range	10,020 - 10,130
52-Week Range	9,470 - 15,400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 26, 2024

About Choong Ang Vaccine Laboratory

Choong Ang Vaccine Laboratory Co., Ltd., operates as an animal vaccine company, primarily engages in the production and sale of pharmaceutical products that promote animal health and welfare in Korea. Its vaccine products include SuiShot, PoulShot, CaniShot, BoviShot, FeliShot, RabbiShot, and AquaShot for preventing diseases and infection in pigs, poultry, dogs, cattle, cats, rabbits, and fish. The company was founded in 1968 and is based in Daejeon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1968
• Employees: 167
• Stock Exchange: KOSDAQ
• Ticker Symbol: 072020

Financial Performance

In 2022, Choong Ang Vaccine Laboratory's revenue was 39.30 billion, a decrease of -3.95% compared to the previous year's 40.91 billion. Earnings were 4.04 billion, a decrease of -46.80%.